Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer

This study has been completed.
Sponsor:
Information provided by:
INSYS Therapeutics Inc
ClinicalTrials.gov Identifier:
NCT00100672
First received: January 4, 2005
Last updated: June 30, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)